Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioLife Solutions, Inc. - Common Stock (NQ:BLFS)

24.20 -0.78 (-3.12%)
Streaming Delayed Price Updated: 10:27 AM EST, Jan 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioLife Solutions, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
BioLife Solutions' CFO Sells 30,000 Shares ↗
This bioproduction tools provider for cell and gene therapy reported a notable insider sale. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BioLife (BLFS) Q3 2025 Earnings Call Transcript ↗
BioLife (BLFS) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
BioLife Solutions Inc (NASDAQ:BLFS) Beats Q3 2025 Earnings and Revenue Estimates ↗
BioLife Solutions Q3 2025 earnings beat estimates with a surprise profit and strong revenue growth, driving a positive market response. 
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
BioLife Solutions Inc (NASDAQ:BLFS) Reports Mixed Q2 2025 Results with Revenue Beat but Profitability Concerns ↗
BioLife Solutions reports Q2 2025 revenue beat but faces profitability challenges, with mixed market reaction. Cell processing growth up 28% YoY. 
Via Chartmill
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Exploring BioLife Solns's Earnings Expectations ↗
 
Via Benzinga
News headline image
Analyst Expectations For BioLife Solns's Future ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 3, 2025 ↗
 
Via Benzinga
News headline image
Key Takeaways From BioLife Solns Analyst Ratings ↗
 
Via Benzinga
News headline image
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024 ↗
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024 ↗
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Recap: BioLife Solns Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 29, 2024 ↗
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
News headline image
Earnings Preview For BioLife Solns ↗
 
Via Benzinga
News headline image
Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling ↗
 
Via Benzinga
News headline image
BioLife Solns: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Over $1M Bet On Carnival? Check Out These 3 Stocks Insiders Are Buying ↗
Although U.S. stocks closed mixed on Monday, there were a few notable insider trades. 
Via Benzinga
News headline image
Top 5 Health Care Stocks That Could Blast Off This Month ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Why Shares of BioLife Solutions Plummeted This Week ↗
The company saw revenue decline, year over year, in the second quarter. 
Via The Motley Fool
News headline image
Why Shares of BioLife Solutions Are Slumping on Wednesday ↗
The company reported declining revenue and reduced annual guidance. 
Via The Motley Fool
News headline image
BioLife Solns: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session ↗
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023 ↗
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.